These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27301947)

  • 1. Use of Antithrombotic Therapy and Long-Term Clinical Outcome Among Patients Surviving Intracerebral Hemorrhage.
    Ottosen TP; Grijota M; Hansen ML; Brandes A; Damgaard D; Husted SE; Johnsen SP
    Stroke; 2016 Jul; 47(7):1837-43. PubMed ID: 27301947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
    Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy.
    Gathier CS; Algra A; Rinkel GJ; van der Worp HB
    Cerebrovasc Dis; 2013; 36(1):33-7. PubMed ID: 23920426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
    Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.
    Lip GY; Clementy N; Pericart L; Banerjee A; Fauchier L
    Stroke; 2015 Jan; 46(1):143-50. PubMed ID: 25424474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study.
    Lamberts M; Lip GY; Hansen ML; Lindhardsen J; Olesen JB; Raunsø J; Olsen AM; Andersen PK; Gerds TA; Fosbøl EL; Torp-Pedersen C; Gislason GH
    Ann Intern Med; 2014 Nov; 161(10):690-8. PubMed ID: 25402512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study.
    Staerk L; Lip GY; Olesen JB; Fosbøl EL; Pallisgaard JL; Bonde AN; Gundlund A; Lindhardt TB; Hansen ML; Torp-Pedersen C; Gislason GH
    BMJ; 2015 Nov; 351():h5876. PubMed ID: 26572685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
    van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
    Trials; 2015 Sep; 16():393. PubMed ID: 26340977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
    Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
    Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic therapy and outcomes after ICD implantation in patients with atrial fibrillation and coronary artery disease: an analysis from the National Cardiovascular Data Registry (NCDR)®.
    Ghanbari H; Nallamothu BK; Wang Y; Curtis JP
    J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)].
    Mazzone C; Carriere C; Grande E; Iorio AM; Barbati G; Zecchin M; Serdoz LV; Cioffi G; Tarantini L; Sinagra G; Scardi S; Di Lenarda A
    G Ital Cardiol (Rome); 2015 Jun; 16(6):361-72. PubMed ID: 26156697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation.
    Pennlert J; Asplund K; Carlberg B; Wiklund PG; Wisten A; Åsberg S; Eriksson M
    Stroke; 2015 Aug; 46(8):2094-9. PubMed ID: 26159794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry.
    Königsbrügge O; Simon A; Domanovits H; Pabinger I; Ay C
    BMC Cardiovasc Disord; 2016 Dec; 16(1):254. PubMed ID: 27938343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE.
    Goto S; Merrill P; Wallentin L; Wojdyla DM; Hanna M; Avezum A; Easton JD; Harjola VP; Huber K; Lewis BS; Parkhomenko A; Zhu J; Granger CB; Lopes RD; Alexander JH
    Eur Heart J Cardiovasc Pharmacother; 2018 Apr; 4(2):75-81. PubMed ID: 29385429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Previous Antithrombotic Therapy, Particularly Anticoagulant, Is Associated with Unfavorable Outcomes in Patients with Primary Spontaneous Intracerebral Hemorrhage Receiving Craniotomy: A Nationwide Population-Based Cohort Study.
    Liu ZH; Chen NY; Tu PH; Yip PK; Wang YC; Chen CC; Chuang CC; Liu CH; Hsu PW; Lin YS
    World Neurosurg; 2019 Aug; 128():e59-e73. PubMed ID: 30954751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet and anticoagulant therapy after intracerebral hemorrhage.
    Zazulia A
    Neurol Clin; 2015 May; 33(2):329-45. PubMed ID: 25907909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.